Fenretinide as an anti-angiogenic agent in neuroblastoma

Cancer Letters

Volumn 197, Issue 1-2, 2003, Pages 181-184

  Ribatti, Domenico ^a   Raffaghello, Lizzia ^b   Marimpietri, Danilo ^b   Cosimo, Emilio ^b   Montaldo, P Giuseppe ^b   Nico, Beatrice ^a   Vacca, Angelo ^a   Ponzoni, Mirco ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Angiogenesis; Anti angiogenesis; Endothelial cells; Fenretinide; HPR; Neuroblastoma; Progression; Therapy; TNP 470; Vascular network

Indexed keywords

ANGIOGENESIS INHIBITOR; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; FENRETINIDE; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; PACLITAXEL; RETINOID;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CARCINOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFICACY; ENDOTHELIUM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DYNAMICS; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR CELL LINE; TUMOR GROWTH;

EID: 0038782392     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00105-8     Document Type: Conference Paper

References (15)

1. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
2. Folkman J. Tumor angiogenesis. Holland J.F., Bast R.C., Morton D.L., Frei E., Kufe D.W., Weichselbaum A. Cancer Medicine. 1997;181-204 Williams and Wilkins, Baltimore.
3. Kleinman N.R., Lewandowska K., Culp L.A. Tumor progression of human neuroblastoma cells tagged with a lacZ marker gene; earliest events at ectopic injection sites. Br. J. Cancer. 69:1994;670-679.
4. Meitar D., Crawford S.E., Rademaker A.W., Cohn S.L. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J. Clin. Oncol. 14:1996;405-414.
5. Ribatti D., Alessandri G., Vacca A., Iurlaro M., Ponzoni M. Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo. Int. J. Cancer. 77:1998;449-454.
6. Canete A., Navarro S., Bermudez J., Pellin A., Castel V., Llombart-Bosch A. Angiogenesis in neuroblastoma: relationship to survival and other prognostic factors in a cohort of neuroblastoma patients. J. Clin. Oncol. 18:2000;27-34.
7. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1971;1182-1186.
8. Wassberg E., Pahlman S., Westlin J.E., Christofferson R. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats. Pediatr. Res. 141:1997;327-333.
9. Nagabuchi E., Vanderkolk W.E., Wney Y., Ziegler M.M. TNP-470 antiangiogenic therapy for advanced nurine neuroblastoma. J. Pediatr. Surg. 32:1997;287-293.
10. Katzenstein H.M., Ademaker A.W., Senger C., Salwen H.R., Nguyen N.N., Thorner P.S., Litsas L., Cohn S.L. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with the tumor burden. Clin. Cancer Res. 5:1999;4273-4278.
11. Wassberg E., Hedborg F., Skoldenberg E., Stridsberg M., Christofferson R. Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma. Am. J. Pathol. 154:1999;395-403.
12. Shusterman S., Grupp S.A., Maris J.M. Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470. Med. Pediatr. Oncol. 35:2000;673-676.
13. Ribatti D., Alessandri G., Baronio M., Raffaghello L., Cosimo E., Marimpetri D., Montaldo P.G., De Falco G., Caruso A., Vacca A., Ponzoni M. Inhibition of neuroblastoma-induced angiogenesis by fenretinide. Int. J. Cancer. 94:2001;314-321.
14. Majewski S., Szmurlo A., Marczak M., Jablonska S., Bollag W. Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on hpv-harboring tumor-cell lines. Int. J. Cancer. 57:1994;81-85.
15. Pienta K.J., Nguyen N.M., Lehr J.E. Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide. Cancer Res. 53:1993;224-226.